The Scientist

» regulation and ecology

Most Recent

image: Jason Holliday: Tree Tracker

Jason Holliday: Tree Tracker

By | February 1, 2016

Associate Professor, Virginia Tech, Department of Forest Resources and Environmental Conservation. Age: 37

0 Comments

image: Theranos in Hot Water with CMS

Theranos in Hot Water with CMS

By | January 29, 2016

The blood-testing company must respond to the US Centers for Medicare and Medicaid Services’ allegations of substandard conditions at one of its labs.

0 Comments

image: Picking Up the Pace

Picking Up the Pace

By | January 1, 2016

FDA designations promise to expedite the approval of drugs for conditions ranging from infectious disease to cancer.

0 Comments

image: Diagnostics Group Refutes FDA’s Concerns

Diagnostics Group Refutes FDA’s Concerns

By | December 17, 2015

The Association for Molecular Pathology finds fault in the agency’s report on safety issues associated with certain lab tests.

0 Comments

image: Owl Be Darned

Owl Be Darned

By | December 4, 2015

Researchers studying city-dwelling birds are learning about which animals are more suited to urban life.

1 Comment

image: A Rainforest Chorus

A Rainforest Chorus

By | December 1, 2015

Researchers measure the health of Papua New Guinea’s forests by analyzing the ecological soundscape.

0 Comments

image: Jungle Field Trip

Jungle Field Trip

By | December 1, 2015

Travel to remote rain forests in Papua New Guinea with researchers from The Nature Conservancy who are working with native people to characterize ecosystems there using sound.

0 Comments

image: Urban Owl-Fitters

Urban Owl-Fitters

By | December 1, 2015

How birds with an innate propensity for living among humans are establishing populations in cities

0 Comments

image: Spiders, Prey Leave DNA

Spiders, Prey Leave DNA

By | November 30, 2015

A study of black widow spiders suggests that the arachnids leave traces of their own genetic material and DNA from prey in their sticky webs.

0 Comments

image: Fatal-Disease Drug in Limbo

Fatal-Disease Drug in Limbo

By | November 25, 2015

A panel of experts advised the US Food and Drug Administration that BioMarin Pharmaceutical has not demonstrated efficacy of its new drug for Duchenne muscular dystrophy.

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech